Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Terminated1
Other1

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT04789096Phase 2Terminated
Tucatinib Together With Pembrolizumab and Trastuzumab
Breast CancerHER2-positive Breast Cancer
StudychairStart date: 2023-03-07
NCT03464942Phase 2Completed
Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2018-08-01

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peter MacCallum Cancer Centre, Australia

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04789096Phase 2StudyChair

Tucatinib Together With Pembrolizumab and Trastuzumab

Breast CancerHER2-positive Breast Cancer
Terminated
NCT03464942Phase 2PrincipalInvestigator

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer

Breast Cancer
Completed
NCT07465172Not ApplicableStudyChair

GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer

Breast Cancer
Not Yet Recruiting

All 3 trials loaded